Research progress of anti-VEGF for the therapy in wet age - related macular degeneration
10.3980/j.issn.1672-5123.2016.10.14
- VernacularTitle:治疗湿性年龄相关性黄斑变性的抗VEGF药物研究进展
- Author:
Wang, LU
;
Peng, HUI
- Publication Type:Journal Article
- Keywords:
wet age-related macular degeneration;
anti-VEGF therapy;
research progress
- From:
International Eye Science
2016;16(10):1847-1851
- CountryChina
- Language:Chinese
-
Abstract:
Wet age-related macular degeneration is the leading cause of the severe, irreversible vision loss in individuals over the age of 65 years. Anti-VEGF therapy has been shown to play a key role in the pathogenesis of wAMD, which is the front-line therapy admittedly. lt has no clear steady curative effect for some patients even if they accepted repeating Anti-VEGF therapy. For the purpose of visual acuity improved more, a steady flow of new therapy has emerged, such as function towards the same or different targets of antiangiogenesis, consolidating the effect by combination therapy, improving or simplifying the mode of administration, etc. This paper gives a brief review of the progress of anti-VEGF for the therapy in wet age-related macular degeneration.
